Tag: CBT > DEA Cannabis Policy and Legalization: Page 5

Top Stories

The DEA Acknowledged That Cannabis Seeds Are Legal to Sell. So, What Does That Mean for the Industry?

An official determination from the DEA could draw the cannabis genetics market into the mainstream—if that’s what breeders and growers want.

November 1, 2022

Interviews & Opinion

FDA Issues First Batch of Warning Letters to Delta-8 THC Product Manufacturers

The federal agency is warning five companies that they are marketing unapproved new drugs, misbranding their wares and unlawfully adding delta-8 THC to food products.

May 6, 2022

Compliance

Federally Approved Cannabis?

Pennsylvania-based Groff North America has begun growing DEA-approved cannabis for FDA clinical trials.

March 9, 2022

Nevada

Scottsdale Research Institute’s Sue Sisley Announced as Day 2 Keynote at Cannabis Conference 2021

Sisley will explain her journey throughout the early days of medical cannabis research—including breakthrough discoveries—and the legal battle that she endured which ended the government’s long-standing cannabis research monopoly.

August 16, 2021

Legislation and Regulation

Industry Weighs in on DEA Cannabis Research Final Rule

Stakeholders express concern that the agency will weigh applicants’ compliance with federal law when granting registrations.

December 23, 2020

Dispensary

Key Congressional Committee Advances Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products

Members of the House Energy and Commerce Committee have voted in favor of a substitute version of Congressman Earl Blumenauer's HR 3797: The Marijuana Research Act of 2019.

September 14, 2020

Interviews & Opinion

Federal Government Sues California Bureau of Cannabis Control for Business Records

The DEA and DOJ have requested specific information about three state-licensed cannabis operators as part of a criminal investigation, and the BCC has refused to provide the information.

August 12, 2020

Legislation and Regulation

Reflecting on How Cannabis Legalization Can Help Stop Oppressive Policing and Foster Racial Justice

A letter from Marijuana Policy Project Executive Director Steve Hawkins.

June 5, 2020

Legislation and Regulation

U.S. House Includes SAFE Banking Act in New COVID-19 Relief Bill, Montana Cannabis Legalization Campaign Launches Signature Drive: Week in Review

This week, House lawmakers included legislative language from the SAFE Banking Act in new legislation aimed at economic relief amid the coronavirus pandemic.

May 16, 2020

Compliance

NCIA Calls for Cannabis Oversight Change

In comments to the DEA’s request for information, NCIA advises cannabis research be overseen by health agency.

May 13, 2020

Interviews & Opinion

Inside the DEA’s New Promise to Expand Cannabis Cultivation for Research

The Drug Enforcement Administration’s draft rules for the program have been met with mixed industry reactions, but Colorado-based MedPharm is encouraged by the progress.

April 24, 2020

Legislation and Regulation

USDA Releases Interim Hemp Regulations, Massachusetts Governor Pursues Emergency Regulation for Vape Ban: Week in Review

Now that the White House Office of Management and Budget has given the go-ahead to the USDA’s federal hemp regulations, the draft of interim rules for the industry is live.

November 2, 2019